[ad_1] SHANGHAI, 7 février 2025 /PRNewswire/ — Shanghai Henlius Biotech, Inc. (2696.HK) a annoncé aujourd’hui qu’elle avait conclu un accord de licence avec Dr. Reddy’s Laboratories SA, filiale à 100 % de Dr Reddy’s Laboratories Ltd., (BSE : […]
Tag: Henlius
Henlius Receives Positive CHMP Opinion for HANSIZHUANG as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
[ad_1] HANSIZHUANG (serplulimab) is the world’s first anti-PD-1 mAb for first-line treatment of ES- SCLC – HANSIZHUANG (serplulimab) is expected to become the first and only anti-PD-1 monoclonal antibody available in Europe for first-line treatment of […]
